The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease.
about
Liver macrophages in tissue homeostasis and disease.Macrophage activation marker sCD163 correlates with accelerated lipolysis following LPS exposure: a human-randomised clinical trial.Editorial: measuring inflammatory and fibrotic components of portal hypertension - a non-invasive hepatic venous pressure gradient? Authors' reply.Apoptosis and non-alcoholic fatty liver diseases.High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study
P2860
The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
The macrophage activation mark ...... alcoholic fatty liver disease.
@en
The macrophage activation mark ...... alcoholic fatty liver disease.
@nl
type
label
The macrophage activation mark ...... alcoholic fatty liver disease.
@en
The macrophage activation mark ...... alcoholic fatty liver disease.
@nl
prefLabel
The macrophage activation mark ...... alcoholic fatty liver disease.
@en
The macrophage activation mark ...... alcoholic fatty liver disease.
@nl
P2093
P2860
P50
P356
P1433
P1476
The macrophage activation mark ...... -alcoholic fatty liver disease
@en
P2093
Bo Martin Bibby
Duncan McLeod
Elisabetta Bugianesi
Ezio David
Hendrik Vilstrup
Henning Grønbaek
Jacob George
Konstantin Kazankov
Mohammed Eslam
Saeed Esmaili
P2860
P304
P356
10.1111/LIV.13150
P577
2016-05-12T00:00:00Z